FDI-6
FDI-6 is an inhibitor of FOXM1. FDI-6 binds directly to FOXM1 protein, to displace FOXM1 from genomic targets in MCF-7 breast cancer cells, and induce concomitant transcriptional down-regulation.
Product Specifications
CAS Number
[313380-27-7]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FDI-6.html
Purity
99.60
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(C1=C(N)C2=C(C(F)(F)F)C=C(C3=CC=CS3)N=C2S1)NC4=CC=C(F)C=C4
Molecular Formula
C19H11F4N3OS2
Molecular Weight
437.43
Precautions
H315, H319, H335
References & Citations
[1]Gormally MV, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nat Commun. 2014 Nov 12;5:5165.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human C5orf24 shRNA (UAS) - Lentiviral human C5orf24 shRNA (UAS, iRFP) plasmid
Mouse Monoclonal Prolactin Antibody (OTI6B1) [Janelia Fluor 646]